Shares of Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA) fell sharply on Friday, September 26, after the US announced a 100% tariff on branded and patented drug imports starting October 1. The stock opened at INR 1,585 against its previous close of INR 1,627.40, and by 9:45 AM, it was trading at INR 1,584.50, down 2.64% in early trade. The tariff announcement impacted Sun Pharma’s key speciality products, including Illumya, Cequa, Odomzo, and Winlevi, which account for 19.3% of the company’s overall sales. The tariffs will not apply to companies with existing or under-construction US plants, providing limited relief for some exporters. The company’s 52-week high stands at INR 1,960.35, while the 52-week low is INR 1,548.00, reflecting recent market volatility. Stocks to Buy or Sell Today, September 26, 2025: Indraprastha Gas, Tata Steel, Jio Financial Among Shares That May Remain in Focus on Friday.

Sun Pharma Share Price Today, September 26: 

Sun Pharma Share Price on NSE (Photo Credits: nseindia.com)
TruLY Score by LatestLY
Rating:5

TruLY Score 5 – Trustworthy | On a Trust Scale of 0-5 this article has scored 5 on LatestLY. It is verified through official sources (NSE Website). The information is thoroughly cross-checked and confirmed. You can confidently share this article with your friends and family, knowing it is trustworthy and reliable.

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)